These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7107372

  • 1. Radiosensitization of the RIF-1 murine flank tumor by desmethylmisonidazole (Ro 05 9963) during interstitial brachytherapy.
    Bernstein M, Gutin PH, Deen DF, Weaver KA, Levin VA, Barcellos MH.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):487-90. PubMed ID: 7107372
    [Abstract] [Full Text] [Related]

  • 2. Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
    Sheldon PW, Fowler JF.
    Br J Cancer Suppl; 1978 Jun; 3():242-5. PubMed ID: 277239
    [Abstract] [Full Text] [Related]

  • 3. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK, Hurst S, Begg AC, Brown JM.
    Cancer Clin Trials; 1980 Jun; 3(3):257-65. PubMed ID: 7438323
    [Abstract] [Full Text] [Related]

  • 4. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T, Nakajima T, Onoyama Y, Nagasawa H, Hori H, Inayama S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May 25; 52(5):688-90. PubMed ID: 1508643
    [Abstract] [Full Text] [Related]

  • 5. Relative biological effectiveness of 125I sources in a murine brachytherapy model.
    Da Silva VF, Gutin PH, Deen DF, Weaver KA.
    Int J Radiat Oncol Biol Phys; 1984 Nov 25; 10(11):2109-11. PubMed ID: 6490435
    [Abstract] [Full Text] [Related]

  • 6. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
    Honess DJ, Wasserman TH, Workman P, Ward R, Bleehen NM.
    Int J Radiat Oncol Biol Phys; 1988 Sep 25; 15(3):671-5. PubMed ID: 2971028
    [Abstract] [Full Text] [Related]

  • 7. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
    Brown JM, Yu NY, Brown DM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1981 Jun 25; 7(6):695-703. PubMed ID: 6457018
    [No Abstract] [Full Text] [Related]

  • 8. Morphological changes in rat hepatocytes in primary culture induced by Misonidazole, desmethylmisonidazole and Ro 03-8799.
    Smith RA.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984 Jun 25; 46(1-2):65-76. PubMed ID: 6147929
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC, Rupp WD, Rockwell S.
    Radiat Res; 1986 Feb 25; 105(2):227-39. PubMed ID: 3754053
    [Abstract] [Full Text] [Related]

  • 10. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N, Persky L.
    Invest Urol; 1981 Jul 25; 19(1):14-6. PubMed ID: 7251317
    [Abstract] [Full Text] [Related]

  • 11. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J.
    Cancer Clin Trials; 1980 Jul 25; 3(2):139-48. PubMed ID: 7428137
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM, Yu NY, Brown JM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1982 Jul 25; 8(3-4):435-8. PubMed ID: 7107364
    [Abstract] [Full Text] [Related]

  • 13. Azomycin riboside: a new radiosensitizer.
    Pedersen JE, Barron G, Chapman JD.
    Int J Radiat Oncol Biol Phys; 1982 Jul 25; 8(3-4):415-8. PubMed ID: 7107360
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G, Canal P, Mockey E, Vandevoorde E, Laurent F, Soula G.
    J Pharmacol; 1983 Jul 25; 14(1):67-77. PubMed ID: 6834852
    [Abstract] [Full Text] [Related]

  • 15. [Radiosensitizing effect of misonidazole on intracranially transplanted tumors in mice and its clinical application (author's transl)].
    Otsuka S, Suda K, Yumitori K, Yamashita J, Oda Y, Takeuchi J, Handa H, Ono K.
    Neurol Med Chir (Tokyo); 1982 May 25; 22(5):337-43. PubMed ID: 6180334
    [No Abstract] [Full Text] [Related]

  • 16. A rapid-mix study on the effect of lipophilicity of nitroimidazoles on the radiosensitization of mammalian cells in vitro.
    Watts ME, Hodgkiss RJ, Jones NR, Sehmi DS, Woodcock M.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Mar 25; 43(3):329-36. PubMed ID: 6601082
    [Abstract] [Full Text] [Related]

  • 17. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
    Rofstad EK, Brustad T.
    Br J Radiol; 1978 May 25; 51(605):381-6. PubMed ID: 638410
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG, Russo A, Gamson J, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1989 Apr 25; 16(4):1021-4. PubMed ID: 2522917
    [Abstract] [Full Text] [Related]

  • 19. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
    Chaplin DJ, Durand RE, Stratford IJ, Jenkins TC.
    Int J Radiat Oncol Biol Phys; 1986 Jul 25; 12(7):1091-5. PubMed ID: 3755714
    [Abstract] [Full Text] [Related]

  • 20. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues.
    Watts ME, Jones NR.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun 25; 47(6):645-53. PubMed ID: 3873434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.